They have also incorporated a new wholly owned subsidiary called Kotyark Bio Specialty Ltd.
The only description provided about the business of this company, is that it will deal in advance Glycerin.
This information can be found here
Company seems to have great potential to create wealth for the share holders. The only concern for me is governance and execution and they seem to lack in both as pointed in this discussion.
i don’t understand why they are raising capital through preferential issue(of 55 Cr). they seem to have great order pipeline of worth more than 1500 Cr. they could easily make this money and pay within a year.
I would appreciate if someone can shed more light on these issues.
Disclaimer: Invested
| Subscribe To Our Free Newsletter |
